Loreto Boix

5.8k total citations · 2 hit papers
68 papers, 4.4k citations indexed

About

Loreto Boix is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Loreto Boix has authored 68 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hepatology, 24 papers in Epidemiology and 22 papers in Molecular Biology. Recurrent topics in Loreto Boix's work include Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Liver Disease Diagnosis and Treatment (17 papers) and Liver physiology and pathology (11 papers). Loreto Boix is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Liver Disease Diagnosis and Treatment (17 papers) and Liver physiology and pathology (11 papers). Loreto Boix collaborates with scholars based in Spain, United States and Italy. Loreto Boix's co-authors include Jordi Bruix, Josep M. Llovet, R. Vilana, Carmen Ayuso, Concepció Brú, Manel Solé, Antoni Castells, María Sala, Lluís Bianchi and Alejandro Forner and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Loreto Boix

64 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma

2007 729 citations Alejandro Forner, R. Vilana et al. Hepatology profile →
Increased Risk of Tumor Seeding After Percutaneous Radiofrequency Ablation for Single Hepatocellular Carcinoma

2001 565 citations Josep M. Llovet, R. Vilana et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Loreto Boix Spain	29	2.7k	1.9k	1.1k	845	810	68	4.4k
Giuliana Amaddeo France	21	1.8k 0.7×	1.2k 0.6×	1.1k 1.0×	1.1k 1.3×	914 1.1×	48	3.8k
Mary A. Maluccio United States	26	1.7k 0.7×	1.0k 0.5×	1.2k 1.1×	1.1k 1.3×	662 0.8×	77	4.4k
Luca Di Tommaso Italy	38	1.5k 0.6×	1.2k 0.6×	1.2k 1.2×	1.6k 1.8×	1.0k 1.3×	162	4.7k
Jun Itakura Japan	37	1.8k 0.7×	1.6k 0.9×	947 0.9×	1.1k 1.3×	467 0.6×	144	4.0k
Tiziana Camerini Italy	27	1.2k 0.5×	928 0.5×	1.2k 1.1×	1.2k 1.5×	594 0.7×	39	3.5k
Sheng‐Long Ye China	32	1.5k 0.5×	689 0.4×	1.5k 1.4×	1.0k 1.2×	897 1.1×	125	3.8k
Toshiya Kamiyama Japan	35	1.5k 0.6×	741 0.4×	720 0.7×	1.1k 1.3×	423 0.5×	192	3.7k
Louis Libbrecht Belgium	48	3.5k 1.3×	2.1k 1.1×	2.1k 2.0×	2.0k 2.3×	976 1.2×	170	7.5k
Fukuo Kondo Japan	34	1.8k 0.7×	1.3k 0.7×	398 0.4×	1.1k 1.3×	312 0.4×	140	3.7k
Hiroshi Obata Japan	26	2.6k 1.0×	1.7k 0.9×	496 0.5×	607 0.7×	525 0.6×	106	3.8k

Countries citing papers authored by Loreto Boix

Since Specialization

Citations

This map shows the geographic impact of Loreto Boix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loreto Boix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loreto Boix more than expected).

Fields of papers citing papers by Loreto Boix

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loreto Boix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loreto Boix. The network helps show where Loreto Boix may publish in the future.

Co-authorship network of co-authors of Loreto Boix

This figure shows the co-authorship network connecting the top 25 collaborators of Loreto Boix. A scholar is included among the top collaborators of Loreto Boix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loreto Boix. Loreto Boix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Armasu, Sebastian M., Irene K. Yan, Fowsiyo Ahmed, et al.. (2025). Association of Epigenetic Aging Biomarkers With Risk of MASLD ‐Related HCC. Liver International. 46(1). e70464–e70464.

Corominas, Josep, Neus Llarch, Marco Sanduzzi‐Zamparelli, et al.. (2025). Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages. Frontiers in Immunology. 16. 1611365–1611365.

Tutusaus, Anna, Marco Sanduzzi‐Zamparelli, Loreto Boix, et al.. (2024). Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular Carcinoma. Cancers. 16(8). 1491–1491. 4 indexed citations

Ribera, Jordi, Montse Pauta, Gregori Casals, et al.. (2023). Liver FoxO1 overexpression is positively associated with the degree of liver injury in cirrhotic patients. SHILAP Revista de lepidopterología. 4(3). 218–226. 2 indexed citations

Herranz, José M., María Elizalde, Juan P. Unfried, et al.. (2022). DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis. Cancers. 14(9). 2048–2048. 6 indexed citations

Cucarull, Blanca, Anna Tutusaus, Milica Stefanović, et al.. (2020). Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models. Cancers. 12(2). 332–332. 22 indexed citations

Al‐Abdulla, Ruba, Marta R. Romero, Rocı́o I.R. Macı́as, et al.. (2020). Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(5). 165687–165687. 13 indexed citations

Unfried, Juan P., Guillermo Serrano, Celia Prior, et al.. (2019). Identification of Coding and Long Noncoding RNAs Differentially Expressed in Tumors and Preferentially Expressed in Healthy Tissues. Cancer Research. 79(20). 5167–5180. 28 indexed citations

Tutusaus, Anna, Milica Stefanović, Loreto Boix, et al.. (2018). Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma. Oncotarget. 9(24). 16701–16717. 48 indexed citations

10.

Friesland, Martina, Mairene Coto‐Llerena, Sofía Pérez‐del‐Pulgar, et al.. (2014). Selective Inhibition of Hepatitis C Virus Infection by Hydroxyzine and Benztropine. Antimicrobial Agents and Chemotherapy. 58(6). 3451–3460. 21 indexed citations

11.

Tremosini, Silvia, Alejandro Forner, Loreto Boix, et al.. (2012). Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma. Gut. 61(10). 1481–1487. 133 indexed citations

12.

Tremosini, Silvia, Alejandro Forner, Loreto Boix, et al.. (2011). 1016 DIAGNOSIS OF HEPATOCELLULAR CARCINOMA (HCC) ≤2 CM: PROSPECTIVE VALIDATION OF GLYPICAN 3, HEAT-SHOCK PROTEIN 70 AND GLUTAMINE SYNTHETASE S TAINING IN BIOPSY SAMPLES. Journal of Hepatology. 54. S404–S404. 1 indexed citations

13.

Bruix, Jordi, Amelia J. Hessheimer, Alejandro Forner, et al.. (2006). New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene. 25(27). 3848–3856. 119 indexed citations

14.

Bruix, Jordi, Loreto Boix, María Sala, & Josep M. Llovet. (2004). Focus on hepatocellular carcinoma. Cancer Cell. 5(3). 215–219. 480 indexed citations

15.

Smith, M. W., Marcus J. Korth, Loreto Boix, et al.. (2003). Hepatitis C Virus and Liver Disease: Global Transcriptional Profiling and Identification of Potential Markers. Hepatology. 38(6). 1458–1467. 106 indexed citations

16.

Bessa, Xavier, Antoni Castells, Antonio M. Lacy, et al.. (2001). Laparoscopic-assisted vs. open colectomy for colorectal cancer: influence on neoplastic cell mobilization. Journal of Gastrointestinal Surgery. 5(1). 66–73. 31 indexed citations

17.

Castells, Antoni, Jordi Bruix, Carmen Ayuso, et al.. (1995). Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever. Journal of Hepatology. 22(4). 410–415. 77 indexed citations

18.

Castells, Antoni, Jordi Bruix, Concepció Brú, et al.. (1995). Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients. Gastroenterology. 109(3). 917–922. 152 indexed citations

19.

Boix, Loreto, José Luís Rosa, Francesc Ventura, et al.. (1994). c-met mRNA overexpression in human hepatocellular carcinoma. Hepatology. 19(1). 88–91. 97 indexed citations

20.

Boix, Loreto, Jordi Bruix, Elı́as Campo, et al.. (1994). nm23-H1 Expression and disease recurrence after surgical resection of small hepatocellular carcinoma. Gastroenterology. 107(2). 486–491. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact